Company / Operating Income per Share
AVADEL PHARMACEUTICALS PLC Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.45
FY2024
5-year range
-$1.72 / $0.11
FY2020-FY2024
Trend
+74.1%
vs FY2023
Sector context
#72 of 201
Health Care
What the data says
At $-0.45, AVADEL PHARMACEUTICALS PLC's operating income per share ranks #72 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2024 after 3 years of decline, reaching $-0.45.
Based on SEC 10-K filings.
-0.45 in FY2024.
Improved from $-1.64 to $-0.45 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#72 of 201 in Health CareTop 36% of 201This company -$0.45 Sector average -$28.56
▼
+98.4% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 74.1% year-over-year.
- Ranks #72 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.45 | +74.1% |
| FY2023 | -$1.72 | -4.8% |
| FY2022 | -$1.64 | -12.2% |
| FY2021 | -$1.46 | -1480.8% |
| FY2020 | $0.11 | +116.4% |
| FY2019 | -$0.64 | +77.1% |
| FY2018 | -$2.81 | -231.2% |
| FY2017 | $2.14 | +1880.4% |
| FY2016 | -$0.12 | -107.4% |
| FY2015 | $1.62 | +162.7% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026